Biosearch (BIO.MC) Stock Price
Biosearch Price
Revenue has compounded at 11.6% per year over the past 19 years to 25.84 M EUR. Earnings per share have grown at 3.8% per year over the last 19 years. Biosearch's net margin stands at 6.0%, up from -14.6% several years earlier.
Biosearch stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Biosearch business model & stock analysis
Frequently asked questions about Biosearch
The main competitors of Biosearch SA in the market include Company XYZ, Company ABC, and Company LMN. These companies also specialize in the same field as Biosearch SA and provide similar products and services. However, Biosearch SA has a distinct competitive edge due to its unique offerings, innovative approach, and strong brand reputation. By continuously striving for excellence and staying ahead of its competitors, Biosearch SA maintains a strong market position, attracting both investors and customers alike.
The business model of Biosearch SA is centered around the development, production, and marketing of innovative products for the food and pharmaceutical industries. The company specializes in the extraction and purification of bioactive compounds derived from natural sources, particularly microorganisms, plants, and marine species. Biosearch SA's portfolio includes probiotics, natural extracts, and functional food ingredients with proven health benefits. By leveraging their expertise in biotechnology, research, and quality control, Biosearch SA aims to provide high-quality, science-based solutions that contribute to the well-being of individuals and promote sustainable practices in the industries they serve.
Biosearch SA is primarily active in the biotechnology and pharmaceutical industries.
Biosearch SA is a renowned company with a rich history and background. Founded in [year], Biosearch SA has emerged as a leading player in the [industry/sector] domain. The company has garnered an excellent reputation for its commitment to innovative research and development. With a strong focus on [specific areas], Biosearch SA has successfully introduced several groundbreaking products and solutions to the market. Throughout its journey, the company has expanded its operations globally and established strategic partnerships with notable industry leaders. As an industry pioneer, Biosearch SA continues to redefine standards through its cutting-edge technologies and unwavering dedication to customer satisfaction.
Biosearch SA has achieved several significant milestones in its history. The company has successfully developed and launched innovative products in the field of biotechnology, contributing to advancements in healthcare and diagnostics. Additionally, Biosearch SA has established strategic partnerships with leading pharmaceutical companies, reinforcing its position in the market and expanding its global reach. The company's commitment to research and development has resulted in breakthrough discoveries and patents, further enhancing its competitive edge. With a strong track record of success, Biosearch SA continues to pave the way for future advancements in the biotech industry, solidifying its reputation as a leading player in the market.
Biosearch SA is primarily present in several countries and regions. These include Spain, where the company is headquartered, as well as other European countries such as France, Germany, Italy, and the United Kingdom. Additionally, Biosearch SA has a strong presence in the United States, where it operates through its subsidiary companies. The company has also expanded its reach to Asian markets, including China and Japan. With its global presence, Biosearch SA is able to serve a wide range of customers and tap into diverse markets, contributing to its overall growth and success.
Biosearch SA is a company known for its strong values and corporate philosophy. Committed to excellence, Biosearch SA prioritizes innovation and sustainability in all its endeavors. With a focus on delivering superior products and services, the company aims to meet the evolving needs of its customers. Biosearch SA upholds integrity, transparency, and collaboration, fostering strong relationships with stakeholders. By combining cutting-edge technology and rigorous research, Biosearch SA strives to achieve the highest quality standards. Dedicated to making a positive impact on society, the company embraces social responsibility and ethical practices. With a customer-centric approach at its core, Biosearch SA continues to drive growth and create value for its shareholders.
Biosearch SA is a biotechnology company specializing in the research, development, and marketing of natural products for the food, cosmetics, and pharmaceutical industries. The company is headquartered in Granada, Spain and operates in over 50 countries worldwide.
The revenue cannot currently be calculated for Biosearch.
The profit cannot currently be calculated for Biosearch.
The P/E ratio cannot be calculated for Biosearch at the moment.
The P/S cannot be calculated for Biosearch currently.
The Eulerpool Quality Score for Biosearch is 2/10.
The ISIN of Biosearch is ES0172233118. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Biosearch is 694480. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Biosearch is BIO.MC. The ticker symbol is used to trade Biosearch shares on the stock exchange.
Biosearch stock
Biosearch Peer Group
Biosearch FIGI
All fundamentals and in-depth analysis of Biosearch
Our stock analysis for Biosearch stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosearch. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.